Genmab A/S Files Form 6-K for April 2025
Ticker: GNMSF · Form: 6-K · Filed: Apr 22, 2025 · CIK: 1434265
| Field | Detail |
|---|---|
| Company | Genmab A/S (GNMSF) |
| Form Type | 6-K |
| Filed Date | Apr 22, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, stock-plan
Related Tickers: GMAB
TL;DR
Genmab filed a 6-K for April, mostly routine stuff for stock plans.
AI Summary
Genmab A/S filed a Form 6-K on April 22, 2025, to report information for the month of April 2025. This filing is incorporated by reference into Genmab's existing S-8 registration statements, which relate to employee stock plans.
Why It Matters
This filing serves as an update for investors and regulatory bodies regarding Genmab's ongoing reporting obligations.
Risk Assessment
Risk Level: low — This is a routine filing that incorporates previous information into existing registration statements and does not appear to contain new material financial or operational disclosures.
Key Players & Entities
- Genmab A/S (company) — Registrant
- April 2025 (date) — Reporting period
- Form 6-K (document) — Filing type
- Form S-8 (document) — Incorporated registration statements
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed for the month of April 2025 and is incorporated by reference into Genmab A/S's registration statements on Form S-8.
What are the Form S-8 registration statements related to?
The Form S-8 registration statements (File Nos. 333-232693, 333-253519, 333-262970, 333-277273 and 333-284876) are related to Genmab A/S's employee stock plans.
When was this report filed?
This report was filed on April 22, 2025.
What is Genmab A/S's principal executive office address?
Genmab A/S's principal executive offices are located at Carl Jacobsens Vej 30, 2500 Valby, Denmark.
Does Genmab A/S file annual reports under Form 20-F or 40-F?
Genmab A/S indicates it files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 22, 2025 regarding GENMAB A/S (GNMSF).